Factors influencing COVID-19 vaccination acceptance when knowing potential side effects A study in Colombia

Published: 2025-12-30

Main Article Content

Authors

Aim
To examine the determinants of COVID-19 vaccine acceptance in Colombia, with particular emphasis on individuals’ responses to possible side effects.

Methods
A cross-sectional study was conducted using an anonymous online questionnaire in Colombia between January and March 2023. The ad hoc survey collected sociodemographic data, COVID-19 history, vaccination status, and adverse effects. Descriptive analyses, chi-square tests, and multinomial logistic regression (aOR, 95% CI) were performed (p <0.05).

Results
The 40.2% of respondents expressed doubts or would have rejected vaccination had they known about possible side effects beforehand. Women were more likely to hold doubts or reject the vaccine after experiencing adverse effects. Participants who experienced side effects were more likely to question their decision to vaccinate. Younger individuals were less likely than older adults to develop negative attitudes after experiencing side effects. Those who had received only one dose were more likely to doubt or reject further vaccination, whereas individuals with multiple doses were less likely to do so. Participants with asymptomatic COVID-19 were less likely to refuse vaccination after learning about potential side effects, possibly because they trusted their immune system more or had a stronger desire to protect others.

Conclusions
Vaccination hesitancy was associated with female sex, prior adverse effects, and fewer doses, whereas younger age was associated with greater acceptance. These findings highlight the need for targeted risk communication to address safety concerns and strengthen vaccine confidence.

Juan Pablo Álvarez Najar, Universidad de los Llanos

orcid_id14.png https://orcid.org/0000-0002-0875-9244

Universidad de Zaragoza, Facultad de Ciencias de la Salud, Zaragoza, Spain
Universidad de los Llanos, Villavicencio, Colombia

Isabel Iguacel, University of Zaragoza

orcid_id14.png https://orcid.org/0000-0003-4242-5464

University of Zaragoza, Facultad de Ciencias de la Salud, Zaragoza, Spain.

University of Zaragoza, Instituto de Investigación Agroalimentario de Aragón, Zaragoza, Spain.

University of Zaragoza, Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain.

Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition, Zaragoza, Spain.

Begoña Martínez-Jarreta, University of Zaragoza

orcid_id14.png https://orcid.org/0000-0001-6469-9189
Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain.
University of Zaragoza, Facultad de Medicina, Zaragoza, Spain.

Sergio Couto-Alfonso, University of Zaragoza

orcid_id14.png https://orcid.org/0009-0003-6068-1231

University of Zaragoza, Facultad de Ciencias de la Salud, Zaragoza, España.

Ignacio de Blas, University of Zaragoza

orcid_id14.png https://orcid.org/0000-0002-1204-4356
University of Zaragoza, Instituto de Investigación Agroalimentario de Aragón, Zaragoza, Spain.
University of Zaragoza,  Facultad de Veterinaria, Departamento de Patología Animal, Zaragoza, Spain.

Factors influencing COVID-19 vaccination acceptance when knowing potential side effects: A study in Colombia. (2025). Colombia Medica, 56(4), e2016609. https://doi.org/10.25100/cm.v56i4.6609

1. Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293-1302. https://doi.org/10.1016/S1473-3099(22)00320-6. PMid:35753318; PMCid:PMC9225255 DOI: https://doi.org/10.1016/S1473-3099(22)00320-6

2. Barbieri V, Wiedermann CJ, Lombardo S, Piccoliori G, Gärtner T, Engl A. Vaccine hesitancy and public mistrust during pandemic decline: findings from 2021 and 2023 cross-sectional surveys in northern Italy. Vaccines (Basel). 2024;12(2):176. https://doi.org/10.3390/vaccines12020176. PMid:38400159; PMCid:PMC10892034 DOI: https://doi.org/10.3390/vaccines12020176

3. Marks P, Califf R. Is vaccination approaching a dangerous tipping point? JAMA. 2024;331(4):283-284. https://doi.org/10.1001/jama.2023.27685. PMid:38180773 DOI: https://doi.org/10.1001/jama.2023.27685

4. Iguacel I, Álvarez-Najar JP, Vásquez PDC, Alarcón J, Orte MÁ, Samatán E, et al. Citizen stance towards mandatory COVID-19 vaccination and vaccine booster doses: a study in Colombia, El Salvador, and Spain. Vaccines (Basel). 2022;10(5):781. https://doi.org/10.3390/vaccines10050781. PMid:35632537; PMCid:PMC9147164 DOI: https://doi.org/10.3390/vaccines10050781

5. European Centre for Disease Prevention and Control. COVID-19 vaccination coverage in the EU/EEA during the 2023-24 season campaigns 1 September 2023 to 31 July 2024. Stockholm: ECDC; 2024. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/covid19-vaccination-coverage-2023-2024.pdf

6. Iguacel I, Maldonado AL, Ruiz-Cabello AL, Samatán E, Alarcón J, Orte MÁ, et al. Attitudes of healthcare professionals and general population toward vaccines and the intention to be vaccinated against COVID-19 in Spain. Front Public Health. 2021;9:739003. https://doi.org/10.3389/fpubh.2021.739003. PMid:34692626; PMCid:PMC8531478 DOI: https://doi.org/10.3389/fpubh.2021.739003

7. Ministerio de Salud y Protección Social. Vacunación contra COVID-19. Bogotá: Ministerio de Salud y Protección Social; cited 9 nov 2025. Available from: https://vacunacion.minsalud.gov.co/EV/Paginas/vacunacion-contra-covid-19.aspx

8. World Health Organization. COVID-19 vaccination for indigenous populations in Colombia. Geneva: WHO; 2021. cited 2025 Nov 9. Available from: https://www.who.int/about/accountability/results/who-results-report-2020-mtr/country-story/2021/colombia

9. Iguacel I, Maldonado AL, Ruiz-Cabello AL, Casaus M, Moreno LA, Martínez-Jarreta B. Association between COVID-19 vaccine side effects and body mass index in Spain. Vaccines (Basel). 2021;9(11):1321. https://doi.org/10.3390/vaccines9111321. PMid:34835252; PMCid:PMC8623604 DOI: https://doi.org/10.3390/vaccines9111321

10. Infectious Diseases Society of America. IDSA Guidelines on the Treatment and Management of Patients with COVID-19. Arlington: IDSA; 2025. Available from: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/

11. Bigdelou B, Sepand MR, Najafikhoshnoo S, Negrete JAT, Sharaf M, Ho JQ, et al. COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes. Front Immunol. 2022;13:890517. https://doi.org/10.3389/fimmu.2022.890517. PMid:35711466; PMCid:PMC9196863 DOI: https://doi.org/10.3389/fimmu.2022.890517

12. Toshkov D. Explaining the gender gap in COVID-19 vaccination attitudes. Eur J Public Health. 2023;33(3):490-495. https://doi.org/10.1093/eurpub/ckad052. PMid:37178211; PMCid:PMC10234652 DOI: https://doi.org/10.1093/eurpub/ckad052

13. Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE, et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021;4(12):e2140364. https://doi.org/10.1001/jamanetworkopen.2021.40364. PMid:34935921; PMCid:PMC8696570 DOI: https://doi.org/10.1001/jamanetworkopen.2021.40364

14. Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021;17(6):1612-1621. https://doi.org/10.1080/21645515.2020.1846397. PMid:33242386; PMCid:PMC8115754 DOI: https://doi.org/10.1080/21645515.2020.1846397

15. Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur. 2021;1:100012. https://doi.org/10.1016/j.lanepe.2020.100012. PMid:33954296; PMCid:PMC7834475 DOI: https://doi.org/10.1016/j.lanepe.2020.100012

16. Xiong X, Yuan J, Li M, Jiang B, Lu ZK. Age and gender disparities in adverse events following COVID-19 vaccination: real-world evidence based on big data for risk management. Front Med (Lausanne). 2021;8:700014. https://doi.org/10.3389/fmed.2021.700014. PMid:34350199; PMCid:PMC8326508 DOI: https://doi.org/10.3389/fmed.2021.700014

17. Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021;10(7):1428. https://doi.org/10.3390/jcm10071428. PMid:33916020; PMCid:PMC8037149 DOI: https://doi.org/10.3390/jcm10071428

18. Real DR, Ortiz IA, Elizeche BS, Zárate CC, Cabrera FA, Monges FH, et al. Aceptación, rechazo y vacilación a recibir la vacuna contra COVID-19: estudio multicéntrico. An Fac Cienc Méd (Asunción). 2023;56(1):25-31. https://doi.org/10.18004/anales/2023.056.01.25 DOI: https://doi.org/10.18004/anales/2023.056.01.25

19. Cerda AA, García LY. Hesitation and refusal factors in individuals' decision-making processes regarding a coronavirus disease 2019 vaccination. Front Public Health. 2021;9:626852. https://doi.org/10.3389/fpubh.2021.626852. PMid:33968880; PMCid:PMC8096991 DOI: https://doi.org/10.3389/fpubh.2021.626852

20. Urrunaga-Pastor D, Bendezu-Quispe G, Herrera-Añazco P, Uyen-Cateriano A, Toro-Huamanchumo CJ, Rodriguez-Morales AJ, et al. Cross-sectional analysis of COVID-19 vaccine intention, perceptions and hesitancy across Latin America and the Caribbean. Travel Med Infect Dis. 2021;41:102059. https://doi.org/10.1016/j.tmaid.2021.102059. PMid:33848692; PMCid:PMC8063600 DOI: https://doi.org/10.1016/j.tmaid.2021.102059

21. Delgado-Gallegos JL, Padilla-Rivas GR, Zúñiga-Violante E, Avilés-Rodríguez G, Arellanos-Soto D, Gastelum-Arias LJ, et al. Determinants of COVID-19 vaccine hesitancy: a cross-sectional study on a Mexican population using an online questionnaire (COV-AHQ). Front Public Health. 2021;9:728690. https://doi.org/10.3389/fpubh.2021.728690. PMid:34900890; PMCid:PMC8661090 DOI: https://doi.org/10.3389/fpubh.2021.728690

22. Valderrama-Orbegozo LJ, Ramírez-Lasprilla LJ, Arce-Leonel DE, Tesfamariam-Ortega MR, Fortich-Pérez DJ. AderVax: Factors related to the acceptance or rejection of the COVID-19 vaccine in 8 cities in Colombia for the development of an intervention. Vaccine X. 2026;28:100767. https://doi.org/10.1016/j.jvacx.2025.100767 DOI: https://doi.org/10.1016/j.jvacx.2025.100767

23. Abel ZDV, Roope LSJ, Duch R, Cole S, Clarke PM. Inequality in COVID-19 vaccine acceptance and uptake: a repeated cross-sectional analysis of COVID vaccine acceptance and uptake in 13 countries. Health Policy. 2025;153:105251. https://doi.org/10.1016/j.healthpol.2025.105251. PMid:39862594 DOI: https://doi.org/10.1016/j.healthpol.2025.105251

24. Bergen N, Kirkby K, Fuertes CV, Schlotheuber A, Menning L, Mac Feely S, et al. Global state of education-related inequality in COVID-19 vaccine coverage, structural barriers, vaccine hesitancy, and vaccine refusal: findings from the Global COVID-19 Trends and Impact Survey. Lancet Glob Health. 2023;11(7):e1082-e1100. https://doi.org/10.1016/S2214-109X(22)00520-4. PMid:36565702; PMCid:PMC9771421 DOI: https://doi.org/10.1016/S2214-109X(22)00520-4

25. Kountouris Y, Remoundou K. Education and vaccine hesitancy: evidence from the COVID-19 pandemic. Economics Letters. 2024;240:111768. https://doi.org/10.1016/j.econlet.2024.111768 DOI: https://doi.org/10.1016/j.econlet.2024.111768

26. Reichelt M, Cullen JP, Mayer-Fried S, Russell HA, Bennett NM, Yousefi-Nooraie R. Addressing COVID-19 vaccine hesitancy in rural communities: A case study in engaging trusted messengers to pivot and plan. Front Public Health. 2023;11:1059067. https://doi.org/10.3389/fpubh.2023.1059067. PMid:36844863; PMCid:PMC9947642 DOI: https://doi.org/10.3389/fpubh.2023.1059067

27. Debbag R, Gallo J, Ávila-Agero ML, Beltrán C, Brea-Del Castillo J, Puentes A, et al. Rebuilding vaccine confidence in Latin America and the Caribbean: strategies for the post-pandemic era. Expert Rev Vaccines. 2025;24(1):581 589. https://doi.org/10.1080/14760584.2025.2527327. PMid:40607738 DOI: https://doi.org/10.1080/14760584.2025.2527327

28. Organisation for Economic Co-operation and Development. Education at a Glance 2021: OECD Indicators. Paris: OECD Publishing; 2021. doi:10.1787/b35a14e5-en. Available from: https://www.oecd.org/en/publications/education-at-a-glance-2021_b35a14e5-en.html

Downloads

Download data is not yet available.